Dexamethasone enhances the antitumor efficacy of Gemcitabine by glucocorticoid receptor signaling

Gemcitabine (Gem) is currently used as the first-line therapy for liver and pancreatic cancer but has limited efficacy in most cases. Dexamethasone (Dex) have been applied as a chemoprotectant and chemosensitizer in cancer chemotherapy. This study further explored the potential of combination of Gem...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Biol Ther
Glavni autori: Gong, Jian-Hua, Zheng, Yan-Bo, Zhang, Meng-Ran, Wang, Yue-Xuan, Yang, Si-Qi, Wang, Rui-Hai, Miao, Qing-Fang, Liu, Xiu-Jun, Zhen, Yong-Su
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2020
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515523/
https://ncbi.nlm.nih.gov/pubmed/31906826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2019.1702399
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items